JPRN-jRCTs061180081
进行中（未招募）
2 期
Preoperative chemoradiothrepy for lower advanced rectal cancer patients using TS-1+Oxaliplatin+Bevacizumab regimen (phase 2 study).
Shimada Mitsuo0 个研究点目标入组 47 人2019年3月20日
概览
- 阶段
- 2 期
- 干预措施
- 未指定
- 疾病 / 适应症
- advanced lower rectal cancer
- 发起方
- Shimada Mitsuo
- 入组人数
- 47
- 状态
- 进行中（未招募）
- 最后更新
- 2年前
概览
简要总结
暂无简介。
研究者
入排标准
入选标准
- •Patients satisfied fully with below criteria
- •1\) Diagnosed as adenocarcinoma
- •2\) cT2\~T4 and cN0\~N3, resectable case
- •3\) Tumor location (including Rb region)
- •4\) Measurable tumor
- •5\) No peritoneal dissemination
- •6\) No distant metastasis
- •7\) 20\~80 years old
- •8\) Performance status 0\~2
- •9\) Patinets with normal organ function
排除标准
- •1\) Interstitial pneumonia
- •2\) Much ascites or pleural effusion
- •3\) Double cancer or treated cancer less than 5 years disease free survival
- •4\) Strong stenosis(fiber cannot pass through)
- •5\) Peritoneal dissemination
- •6\) Infection,Ileus
- •7\) Severe diarrhea
- •8\) Severe diabete mellitus
- •9\) Severe hyper tension
- •10\)Heart failure,liver failure,renal failure
结局指标
主要结局
未指定
相似试验
已完成
1 期
A phase I/II study of preoperative chemoradiotherapy with S-1, Celecoxib and Radiation for locally advanced rectal cancerRectal cancerJPRN-UMIN000012818Department of frontier surgery Graduate school of medicine, Chiba University20
招募中
2 期
A pilot study of the preoperative chemoradiotherapy for T3-4, N0-N2 rectal cancer aiming at sphincter preservation.Rectal cancerJPRN-UMIN000009432Saitama Medical Center, Saitama Medical University28
招募中
2 期
ACRT(GA-RT) vs NAC(GA) for BRPCBorderline resectable pancreatic ductal adenocarcinomaBorderline resectable pancreatic cancer, Prospective randomized control study, Neoadjuvant chemotherapy, Neoadjuvant chemoradiotherapyC535836JPRN-jRCTs051200130Kobayashi Syogo110
已完成
不适用
A phase I/II trial of preoperative chemoradiotherapy with gemcitabine in patients with pancreatic cancer and impaired renal functioJPRN-UMIN000016877Clinical Study Group of Osaka University8
已完成
2 期
Immunotherapy In Locally Advanced Rectal CancerColon Rectal CancerNCT03854799Gruppo Oncologico del Nord-Ovest101